The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis

International Journal of STD and AIDS

Volumn 27, Issue 7, 2016, Pages 568-575

  Zhao, Honglei ^a   Shu, Guobin ^a   Wang, Songting ^a  

^a Ningbo Beilun people Hospital   (China)

Author keywords

AIDS; antiviral; basal cell carcinoma; epidemiology; highly active antiretroviral therapy; HIV; human immunodeficiency virus; skin cancer; squamous cell carcinoma; viral disease

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CANCER RISK; EMBASE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; META ANALYSIS; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; SYSTEMATIC REVIEW; ACQUIRED IMMUNODEFICIENCY SYNDROME; COHORT ANALYSIS; COMPLICATION; FEMALE; HIV INFECTIONS; INCIDENCE; MALE; PATHOLOGY; RISK FACTOR; SKIN NEOPLASMS; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; RISK FACTORS; SKIN NEOPLASMS; VIRAL LOAD;

EID: 84968853329     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462415586316     Document Type: Article

References (26)

1. H.W.RogersM.A.WeinstockA.R.Harris. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol2010; 146: 283–287.
2. T.S.HousmanS.R.FeldmanP.M.Williford. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol2003; 48: 425–429.
3. V.MadanJ.T.LearR.M.Szeimies. Non-melanoma skin cancer. Lancet2010; 375: 673–685.
4. A.E.GrulichM.T.van LeeuwenM.O.Falster. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet2007; 370: 59–67.
5. M.J.SilverbergC.ChaoW.A.Leyden. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev2011; 20: 2551–2559.
6. N.Crum-CianfloneK.H.HullsiekV.Marconi. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS2009; 23: 41–50.
7. L.PantanowitzB.J.Dezube. Evolving spectrum and incidence of non-AIDS-defining malignancies. Curr Opin HIV AIDS2009; 4: 27–34.
8. E.A.Engels. Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS2009; 23: 875–885.
9. E.P.SimardE.A.Engels. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis2010; 51: 957–962.
10. F.SpecchioR.SaracenoS.Chimenti. Management of non-melanoma skin cancer in solid organ transplant recipients. Int J Immunopathol Pharmacol2014; 27: 21–24.
11. J.P.SpanogleY.C.KudvaR.A.Dierkhising. Skin cancer after pancreas transplantation. J Am Acad Dermatol2012; 67: 563–569.
12. G.H.ParkS.E.ChangC.H.Won. Incidence of primary skin cancer after organ transplantation: An 18-year single-center experience in Korea. J Am Acad Dermatol2014; 70: 465–472.
13. L.Dal MasoJ.PoleselD.Serraino. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer2009; 100: 840–847.
14. S.FranceschiM.LiseG.M.Clifford. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer2010; 103: 416–422.
15. L.AlbiniA.CalabresiD.Gotti. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era. AIDS Res Hum Retroviruses2013; 29: 1097–1104.
16. M.J.SilverbergW.LeydenE.M.Warton. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst2013; 105: 350–360.
17. D.F.StroupJ.A.BerlinS.C.Morton. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA2000; 283: 2008–2012.
18. C.B.BeggM.Mazumdar. Operating characteristics of a rank correlation test for publication bias. Biometrics1994; 50: 1088–1101.
19. M.EggerS.G.DaveyM.Schneider. Bias in meta-analysis detected by a simple, graphical test. BMJ1997; 315: 629–634.
20. G.M.AllardiceD.J.HoleD.H.Brewster. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer2003; 89: 505–507.
21. A.NewnhamJ.HarrisH.S.Evans. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer2005; 92: 194–200.
22. M.AlamD.Ratner. Cutaneous squamous-cell carcinoma. N Engl J Med2001; 344: 975–983.
23. A.K.GantiA.Kessinger. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treat Rev2011; 37: 440–443.
24. M.S.ShielsR.M.PfeifferM.H.Gail. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst2011; 103: 753–762.
25. D.V.LoboP.ChuR.C.Grekin. Nonmelanoma skin cancers and infection with the human immunodeficiency virus. Arch Dermatol1992; 128: 623–627.
26. T.A.MaurerK.V.ChristianR.L.Kerschmann. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol1997; 133: 577–583.